
Growth Factor
Ipamorelin
NNC 26-0161
Prices in AUD per vial. Check the selected option; product imagery is illustrative.
- Selected vial size
- 10mg
- Price per vial
- $79.00 AUD
- Payment
- PayID or bank transfer
Free Australian delivery over $250 before discounts; otherwise $12. Express Post dispatch within 1 business day of cleared payment; most metro addresses 1–2 business days after dispatch. Larger sizes are enquiry-only.
Ipamorelin is a pentapeptide studied for its selective action on the ghrelin receptor without materially affecting cortisol or prolactin pathways in research models. Supplied strictly for in-vitro laboratory research use.
Ipamorelin specifications
- Other names
- NNC 26-0161
- Sequence
- Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Length
- 5 residues (C-terminal amide)
- Molecular formula
- C38H49N9O5
- Molecular weight
- 711.9 g/mol
- CAS No.
- 170851-70-4
- Form
- Lyophilized Powder
- Vial size
- 10mg
Sequence, formula and molecular weight are compound reference data, not batch test results.
Ipamorelin price in Australia
$79.00 per 10mg lyophilised powder vial · $7.90 per mg
- 10% off automatically on orders of $300 or more
- 5% off your first order when you join our email list at checkout
- Free Express Post on orders over $250
- Dispatched from Brisbane within one business day of payment
Buying Ipamorelin in Australia
- Where can I buy Ipamorelin in Australia?
- You can buy Ipamorelin 10mg online from Nautic Peptides, an Australian supplier based in Brisbane (Nautic Peptides Pty Ltd, ABN 60 702 527 679). All stock is held in Australia and every order is sent from Brisbane by tracked Express Post.
- Can I buy Ipamorelin online in Australia?
- Yes. Ipamorelin is for sale online at nauticpeptides.com. Add it to your cart, check out in a few steps and pay by PayID or bank transfer, and your order ships once payment is confirmed, typically within 1 business day.
- How much is Ipamorelin in Australia?
- Ipamorelin 10mg is $79.00 per vial ($7.90 per mg) at Nautic Peptides. Orders of $300 or more get 10% off automatically, and delivery is free on orders over $250. A larger 20mg size is available on request.
- Is Ipamorelin available in Australia?
- Yes. Ipamorelin 10mg is available now, in stock in Queensland and ready to dispatch.
- How fast will my Ipamorelin order arrive?
- Orders are dispatched within one business day of payment by tracked Express Post. Australia Post's typical Express Post timeframe between metro areas is 1–2 business days, and you'll receive tracking as soon as your order ships.
- How do I pay for Ipamorelin?
- Pay securely by PayID or direct bank transfer. PayID usually arrives within minutes, and your order ships as soon as payment clears.
Often viewed with Ipamorelin
Supplier certificate of analysis
- Batch no.
- 800046-26031501-04
- Report date
- 15 Mar 2026
- Purity (HPLC), supplier-reported
- 99.8%
- Mass spectrum
- 711.4 (expected 711.9 ± 1.0)
Our current stock of this product was produced from this batch. This is the manufacturer's certificate of analysis for that production batch.
For in-vitro laboratory research only. Not for human or veterinary use.
In the research literature
Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) developed by Novo Nordisk from a series of compounds based on GHRP-1. It acts on the ghrelin receptor, also called the growth hormone secretagogue receptor (GHS-R1a). In the 1998 study that introduced it, ipamorelin released growth hormone from cultured rat pituitary cells with potency and efficacy similar to GHRP-6, with comparable results in anaesthetised rats and conscious swine. Its distinguishing finding was selectivity: in swine, GHRP-6 and GHRP-2 raised ACTH and cortisol, while ipamorelin did not, even at doses more than 200-fold above its ED50 for GH release. A 1999 study in healthy male volunteers reported dose-proportional pharmacokinetics, a terminal half-life of about 2 hours and a single GH pulse peaking around 40 minutes after intravenous infusion. A Phase 2 trial of intravenous ipamorelin for postoperative ileus after bowel surgery (114 evaluable patients) found no significant difference from placebo on its key endpoint, and clinical development did not proceed.
- Raun et al., Eur J Endocrinol (1998) — Ipamorelin, the first selective growth hormone secretagogue
- Gobburu et al., Pharm Res (1999) — pharmacokinetics and GH response in healthy volunteers
- Beck et al., Int J Colorectal Dis (2014) — Phase 2 trial in postoperative ileus
Cited studies describe published research findings, primarily from preclinical or early-phase models. This is not a claim of safety or effectiveness for human use.
Ipamorelin research and related reading
Often researched alongside: CJC-1295 (no DAC) 10mg